Provided by Tiger Trade Technology Pte. Ltd.

Regulus Therapeutics

8.16
0.0000
Volume:- -
Turnover:75.91M
Market Cap:564.95M
PE:-11.28
High:8.16
Open:8.16
Low:8.16
Close:8.16
52wk High:8.35
52wk Low:0.8301
Shares:69.23M
Float Shares:52.94M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7233
EPS(LYR):-0.8227
ROE:-53.82%
ROA:-34.23%
PB:8.18
PE(LYR):-9.92

Loading ...

Regulus Therapeutics Inc : Wells Fargo Cuts to Equal Weight From Overweight; Raises Target Price to $9 From $6

THOMSON REUTERS
·
May 01, 2025

U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics

Reuters
·
May 01, 2025

Regulus Therapeutics Inc : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $7 From $6

THOMSON REUTERS
·
May 01, 2025

Regulus Therapeutics Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
May 01, 2025

Wells Fargo Downgrades Regulus Therapeutics to Equalweight From Overweight, $9 Price Target

MT Newswires Live
·
May 01, 2025

Regulus Therapeutics Cut to Hold From Buy by Jones Trading

Dow Jones
·
May 01, 2025

Regulus Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
May 01, 2025

Top Midday Gainers

MT Newswires Live
·
May 01, 2025

Regulus Shares Surge on $1.7 Billion Acquisition by Novartis

Dow Jones
·
May 01, 2025

S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results

Benzinga
·
Apr 30, 2025

Novartis to Buy Regulus Therapeutics for up to $1.7 Billion

Reuters
·
Apr 30, 2025

Regulus Shares Jump 134% to $7.88 After Novartis Agrees to Buy Co for up to $1.7 Bln

THOMSON REUTERS
·
Apr 30, 2025

BRIEF-Regulus Therapeutics Upon Termination Of Merger Deal Under Some Circumstances, Co To Pay Parent Termination Fee Of $27.3 Million

Reuters
·
Apr 30, 2025

Regulus Therapeutics: Upon Termination of Merger Deal Under Some Circumstances, Co to Pay Parent Termination Fee of $27.3 Mln

THOMSON REUTERS
·
Apr 30, 2025

BUZZ-Regulus Therapeutics' stock price doubles on Novartis's buyout offer

Reuters
·
Apr 30, 2025

Novartis to Acquire Regulus in $1.7B Deal

Dow Jones
·
Apr 30, 2025

Shares of Regulus Therapeutics Jump 130% to $7.77 Premarket After Novartis Agrees to Buy Co for up to $1.7 Bln

THOMSON REUTERS
·
Apr 30, 2025

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal

Reuters
·
Apr 30, 2025

Novartis to Acquire Regulus Therapeutics

MT Newswires Live
·
Apr 30, 2025